About Us
Businesses
Our Impact
News
Insights
Investors
Careers
My Account
Home
/
Insights
/
All Insights
Technology & Innovation
AI & Biopharma – A Quick Take from Amgen
Video
•
October 12, 2023
The importance of AI for Biopharma, in Amgen’s view, and how the company is using it.
Related Stories
Technology & Innovation
AI & Biopharma – A quick take from AstraZeneca
The importance of AI for Biopharma, in the view of Alexion (AstraZeneca’s rare disease unit), and how the company is using it.
Technology & Innovation
AI in Healthcare: Are AI Doctors on Call?
Citi’s Adam Spielman is the author of a series of reports on the impact of AI on the healthcare sector. Here he discusses several aspects of his research including AI’s impact on clinicians, its potential to drastically lessen their administrative burden, and why biopharma could be the area that AI impacts most of all.
Sign up to receive the latest from Citi.
Next